New study tests cheaper chemo options for HIV cancer in africa
NCT ID NCT05411237
First seen Dec 12, 2025 · Last updated May 09, 2026 · Updated 21 times
Summary
This study compares two chemotherapy drugs, paclitaxel and pegylated liposomal doxorubicin, to see if they work similarly well for treating Kaposi sarcoma in people with HIV. The trial will enroll 130 participants in sub-Saharan Africa, giving each drug once every three weeks for six cycles. The main goal is to measure how long the cancer stays under control or improves.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAPOSI SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.